Doctors at the Memorial Sloan-Kettering Cancer Center in New York have hailed the patient's recovery 'one of the most astonishing responses I have seen'
They combined a standard drug already used, ipilimumab and nivolumab, to treat melanoma with a new combination of drugs .
The 49-year-old woman showed a staggering response to the new drug combination .